"10.1371_journal.pone.0032443","plos one","2012-02-27T00:00:00Z","W Gordon Frankle; Raymond Y Cho; N Scott Mason; Chi-Min Chen; Michael Himes; Christopher Walker; David A Lewis; Chester A Mathis; Rajesh Narendran","Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America; Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America","Conceived and designed the experiments: WGF RYC DAL CAM RN. Performed the experiments: NSM CW. Analyzed the data: CMC MH. Wrote the paper: WGF RN.","Dr. Frankle serves as a consultant for Sunovion Pharmaceuticals, Inc. and ONO Pharmaceuticals, Inc. Dr. Narendran has received grant support from GlaxoSmithKline, Inc. and Sunovion Pharmaceuticals, Inc. Dr. Mason serves as a consultant for Aposense Inc., Banner Good Samaritan Hospital (Phoenix, AZ), Janssen AI, and The Gollman Group (Dallas, TX). Dr. Lewis has served as a consultant for Bristol Meyer Squibb, Merck, Lilly, and Hoffman-LaRoche and received research grant support from Merck and Pfizer. Dr. Mathis receives royalty payments from the University of Pittsburgh for technology licensed to GE Healthcare and Neuroptix. He serves as a consultant for Elan, Pfizer, Takeda, Amgen, Baxter Scientific, Novartis, and GE Healthcare. He has received grant support from Neuroptix and GE Healthcare. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Dr. Cho, Ms. Chen, Mr. Himes and Mr. Walker have no conflict of interest to declare.","2012","02","W Gordon Frankle","WGF",9,TRUE,5,2,2,2,TRUE,FALSE,FALSE,0,NA,FALSE
